Skip to main content

bezafibrate

Generic: bezafibrate

bezafibrate: 2 clinical trials tracked.

bezafibrate evidence translation

What we can confirm

2 tracked trials

No verified listed company relationship

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about bezafibrate, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence1 indications · 1 study sponsors
Clinical Trial Registry Records (2)

A Phase 2a, Double-Blind, Randomized, Active Controlled, Parallel Group Study Evaluating the Efficacy, Safety, and Tolerability of Bezafibrate Administered in Combination With Obeticholic Acid in Subjects With Primary Biliary Cholangitis

NCT05239468Registry updated 2025-09-25·Phase 2·ICPT
Completed

Primary endpoint: Change in Alkaline Phosphatase (ALP) from Baseline to Week 12

InterventionalRandomizedquadruple72 enrolledStarted 2022-03Completion 2025-0926 sites · Argentina, Canada, Italy, United StatesIntercept Pharmaceuticals

A Phase 2, Double-Blind, Randomized, Parallel Group Study Evaluating the Efficacy, Safety, and Tolerability of Obeticholic Acid Administered in Combination With Bezafibrate in Subjects With Primary Biliary Cholangitis Who Had an Inadequate Response or Who Were Unable to Tolerate Ursodeoxycholic Acid

NCT04594694Registry updated 2025-11-17·Phase 2·ICPT
Terminated

Primary endpoint: Change in Alkaline Phosphatase (ALP) from baseline to Week 12 in the DB Treatment Period

InterventionalRandomizedquadruple75 targetStarted 2019-10Completion 2025-1033 sites · Australia, Belgium, Croatia, Czechia…Intercept Pharmaceuticals